Replies to post #243565 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Ooohh... "concerns" and "toxicities" doesn't sound very good.

Not at all surprising to me, though.

Upon approval, my guess is that people will choose DCVax L and Direct every time over a CAR-T for solid tumor cancers.

Now WHEN DCVax can be proven to work in blood cancer, it'll be the end of CAR-T.

And that's not even addressing the costs of CAR-T, and simply addressing the toxicities.